JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB208017

Anti-MLLT6 antibody [EPR20977-52]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal MLLT6 antibody. Suitable for WB and reacts with Mouse, Human samples.

View Alternative Names

AF17, MLLT6, Protein AF-17, ALL1-fused gene from chromosome 17 protein

1 Images
Western blot - Anti-MLLT6 antibody [EPR20977-52] (AB208017)
  • WB

Lab

Western blot - Anti-MLLT6 antibody [EPR20977-52] (AB208017)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

This antibody detects an unidentified band above the target band.

Exposure time : 26 seconds.

All lanes:

Western blot - Anti-MLLT6 antibody [EPR20977-52] (ab208017) at 1/1000 dilution

Lanes 1 - 2:

HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg

Lane 3:

K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate at 20 µg

Lane 4:

NIH/3T3 (mouse embryonic fibroblast), whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/25000 dilution

Predicted band size: 112 kDa

Observed band size: 112 kDa

false

  • Carrier free

    Anti-MLLT6 antibody [EPR20977-52] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR20977-52

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Complementary Products

Primary Antibodies

AB239358

Anti-KMT4 / Dot1L antibody [EPR22936-138]

BOND RX™ Validated|RabMAb|Recombinant|Advanced Validation

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KMT4 / Dot1L antibody [EPR22936-138] (AB239358)

  • 0
  • 0
Primary Antibodies

AB109012

Anti-SQSTM1 / p62 antibody [EPR4844] - Autophagosome Marker

20ul selling size|KO Validated|RabMAb|Recombinant|Lab Essentials

Western blot - Anti-SQSTM1 / p62 antibody [EPR4844] - Autophagosome Marker (AB109012)

  • 5
  • 15
Primary Antibodies

AB267388

Anti-Thrombospondin 1 antibody [EPR22927-54]

20ul selling size|BOND RX™ Validated|RabMAb|Recombinant|Advanced Validation

Multiplex immunohistochemistry - Anti-Thrombospondin 1 antibody [EPR22927-54] (AB267388)

  • 2
  • 1
Primary Antibodies

AB252940

Anti-UBE2C antibody [EPR23165-31]

20ul selling size|BOND RX™ Validated|RabMAb|Recombinant|KO Validated

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-UBE2C antibody [EPR23165-31] (AB252940)

  • 0
  • 0
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }
style
left-column

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The MLLT6 protein also known as AF17 functions mechanically as a transcriptional coactivator. It plays a role in regulating gene expression by interacting with other proteins involved in transcriptional control. The protein has a mass of approximately 122 kDa. Researchers identify its expression in various tissues with a significant presence in hematopoietic tissues. MLLT6 interacts closely with other protein partners to modulate the transcriptional machinery.
Biological function summary

MLLT6 acts as a part of larger protein complexes involved in transcription regulation. It influences the activation and repression of specific gene sets necessary for cell differentiation and development. By integrating into these complexes MLLT6 assists in maintaining the proper function of gene expression programs that control cellular identity and activity. Its contribution is important in processes such as hematopoiesis impacting the development and specialization of blood cells.

Pathways

MLLT6 plays a role in key regulatory networks like the mitochondrial apoptosis and Notch signaling pathways. Through interactions within these pathways MLLT6 associates with proteins like MLLT3 and NOTCH1. These relationships help mediate cell survival proliferation and differentiation signals. This pathway integration allows MLLT6 to influence essential cellular processes aligning transcriptional responses with extracellular signals.

MLLT6 shows a strong connection to certain types of leukemia notably acute myeloid leukemia (AML). Dysregulation of MLLT6 can contribute to leukemogenesis by disrupting normal transcriptional programs and signaling pathways. Additionally studies link MLLT6 to neuroblastoma where its aberrant expression intersects with the MLL protein family impacting tumor development. These disease associations highlight MLLT6's potential value as a therapeutic target and a biomarker for specific hematological and neurological malignancies.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

See full target information MLLT6
style
left-column
style
left-column
style
right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com